Medical Companies in Finland

We provide the AI tools for the analysis of brain function in intensive care. CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated technology can be integrated into EEG-measurement devices and patient monitors as a software feature. CERENION C-TREND™ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a set of easy parameters that aid medical professionals in clinical decision making. The patented technology has the potential of improving both the quality and the cost of intensive care. Cerenion™, Cerenion C-Trend™, C-Trend™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. All rights reserved. © Cerenion Oy 2017.

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. The wide-ranging disease risk predictions provided by Nightingale consist of two interconnected factors: The extensive blood analysis technology developed by Nightingale and a large amount of data on health events. Nightingale helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone. We’re a team of 60 members––a diverse bunch with interdisciplinary expertise in business, marketing, computational medicine, data science, healthcare, IT, design and more––who envisage a world that focuses on keeping people healthy rather than just treating illnesses. So, if you are looking to enable good tech that could make a real difference, Nightingale is the place to be.

MVision AI is a mission-oriented startup helping clinicians to save lives. MVision AI specializes in the field of medical imaging and artificial intelligence.

Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient. Synoste utilizes smart materials and introduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life.

PulseOn, a pioneer in optical heart rate (OHR) technology, is a high-tech company specialized in arrhythmia detection devices and analysis software for professional medical use. PulseOn’s unique solution is changing the future of detection of arrhythmias. PulseOn is a privately owned company founded in 2012 and headquartered in Espoo, Finland.

We create the technology that transforms musculoskeletal healthcare. We serve hospitals, orthopedic centers, physical therapy clinics and elderly care centers with the industry's most complete and sophisticated solution. Uncompromised biomechanics combined with intelligent technology produce predictable and documented outcomes with high productivity. www.davidhealth.com

Injeq is developing intelligent medical technology - smart needles - for demanding lumbar punctures and medical injections. The leading product under development is the IQ-Tip® system, which is a novel method for demanding lumbar punctures. The clinical performance and safety of Injeq IQ-Tip® system have already been evaluated in three clinical investigations in university hospitals. The smart needle system is feasible for lumbar punctures from neonates to older adults, including treatment punctures of children with leukemia. Injeq IQ-Tip® products are designed and manufactured to meet the requirements of the new European Medical Device Regulation (MDR 2017/745). European market entry is expected soon. Injeq Quality Management System is certified according to the EN ISO 13485:2016.

The company VitalSignum Oy is based in Helsinki, Finland and was founded in 2015 by a team of top medical and health tech experts from Finland. VitalSignum Oy develops and provides simple, reliable, and easy-to-use mobile health monitoring solutions and services. The company focuses on offering ECG remote monitoring solutions for detecting heart arrhythmia. Vitalsignum Oy has developed Beat2Phone ECG, a wearable medical grade ECG solution that can be worn around the clock and is designed for both individuals and healthcare professionals. Beat2Phone ECG is an ideal device for primary care clinicians, cardiologists, neurologists and elderly home care professionals. Beat2Phone ECG enables a better preventive monitoring and observation of cardiac symptoms leading to cost and time savings in the healthcare and a healthier life for the patients. Beat2Phone ECG consists of a reliable and easy-to-use wearable electrocardiogram (ECG) sensor placed on the chest and connected to a phone app with a cloud analytics service for fast, cost-effective screening of heart problems. Beat2Phone ECG can be comfortably worn by the patient for as long as the symptoms reappear. The system has been designed to be maximally automatic to save the health professionals’ valuable time and effort.